Literature DB >> 7125687

Paediatric continuous ambulatory peritoneal dialysis.

E J Eastham, H Kirpalani, D Francis, R Gokal, R H Jackson.   

Abstract

Ten children in end-stage renal failure were treated by continuous ambulatory peritoneal dialysis (CAPD). This represents a total of 3.4 patient years. Biochemical control was good, and parent and patient acceptability high. Peritonitis was the chief complication, but after the institution of a specific CAPD education and training programme the incidence declined 10-fold. We regard CAPD as an effective short- and medium-term treatment for children with end-stage renal failure as part of an integrated dialysis and transplant programme, but it requires a devoted and enthusiastic trained staff to ensure success.

Entities:  

Mesh:

Year:  1982        PMID: 7125687      PMCID: PMC1627770          DOI: 10.1136/adc.57.9.677

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  4 in total

1.  "Eosinophilic" peritonitis in continuous ambulatory peritoneal dialysis (CAPD).

Authors:  R Gokal; J M Ramos; M K Ward; D N Kerr
Journal:  Clin Nephrol       Date:  1981-06       Impact factor: 0.975

2.  10 years' experience with regular haemodialysis and renal transplantation.

Authors:  C Chantler; J E Carter; M Bewick; R Counahan; J S Cameron; C S Ogg; D G Williams; E Winder
Journal:  Arch Dis Child       Date:  1980-06       Impact factor: 3.791

3.  Continuous ambulatory peritoneal dialysis: one year's experience in a UK dialysis unit.

Authors:  R Gokal; M McHugh; R Fryer; M K Ward; D N Kerr
Journal:  Br Med J       Date:  1980-08-16

4.  Continuous ambulatory peritoneal dialysis.

Authors:  R P Popovich; J W Moncrief; K D Nolph; A J Ghods; Z J Twardowski; W K Pyle
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

  4 in total
  2 in total

1.  Acute renal failure in paediatric patients: the role of continuous haemofiltration.

Authors:  S Fanconi; E P Leumann
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Optimum treatment of end-stage renal failure.

Authors:  M H Winterborn
Journal:  Arch Dis Child       Date:  1983-03       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.